SHERI HAYES-RAULERSON: Open Payments
NPI 1598018582 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,231 in 113 payments from 18 companies in 2025. Trend: 2023 $1,275 · 2024 $1,359 · 2025 $2,231
Food & beverage: $2,231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $479 |
| Phathom Pharmaceuticals, Inc. | 8 | $307 |
| Janssen Biotech, Inc. | 12 | $251 |
| Madrigal Pharmaceuticals | 14 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $169 |
| Regeneron Healthcare Solutions, Inc. | 6 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $113 |
| GENZYME CORPORATION | 4 | $104 |
| Lilly USA, LLC | 5 | $104 |
| Aimmune Therapeutics, Inc. | 4 | $87 |
Products named: VOQUEZNA, TREMFYA, DUPIXENT, REZDIFFRA, RINVOQ, ENTYVIO, CREON, XIFAXAN.
Industry payments across FL — which companies pay providers there.
